Traumatic-Induced Coagulopathy as a Systems Failure: A New Window into Hemostasis

Abstract

Traumatic-induced coagulopathy (TIC) is often associated with significant bleeding, transfusion requirements, inflammation, morbidity, and mortality. This review considers TIC as a systems failure, not as a single-event manifestation of trauma. After briefly reviewing the meaning of TIC and the bewildering array of fibrinolysis phenotypes, we will discuss the role of platelets and fibrinogen in coagulopathy. Next, we will review the different TIC hypotheses and drill down to a single mechanistic domain comprising (1) thrombin's differential binding to thrombomodulin, (2) the expression of annexin II-S100A10 complex, and (3) the functional integrity of the endothelial glycocalyx. This triad forms the basis of the “switch” hypothesis of TIC. We will next address the potential limitations of current practice in treating a coagulation or fibrinolytic defect, and the next defect, and so on down the line, which often leads to what U.S. surgeon William C. Shoemaker considered “an uncoordinated and sometimes contradictory therapeutic outcome.” The treat-as-you-go approach using sequential, single-target treatments appears to be a by-product of decades of highly reductionist thinking and research. Lastly, we will present a unified systems hypothesis of TIC involving three pillars of physiology: the central nervous system (CNS)–cardiovascular system, the endothelial glycocalyx, and mitochondrial integrity. If CNS control of ventriculoarterial coupling is maintained close to unity following trauma, we hypothesize that the endothelium will be protected, mitochondrial energetics will be maintained, and TIC (and inflammation) will be minimized. The Systems Hypothesis of Trauma (SHOT) also helps to answer why certain groups of severely bleeding trauma patients are still dying despite receiving the best care. Currently, no drug therapy exists that targets the whole system.

Keywords

resuscitation - coagulopathy - glycocalyx - endothelium - shock - hemorrhage - ROTEM - TEG - fibrinolysis - injury

Author Contribution

All authors contributed equally to the design, implementation, literature analysis, and writing of the manuscript.

Declaration of Interest

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Department of the Navy, U.S. Department of the Army, U.S. Department of Defense, or the U.S. Government.

• References

• 1 Cannon WB. The Wisdom of the Body. New York, NY: W.W. Norton; 1932
• 2 Dobson GP. Addressing the global burden of trauma in major surgery. Front Surg 2015; 2 (Sept): 43
• 3 Dobson GP, Letson HL, Sharma R, Sheppard FR, Cap AP. Mechanisms of early trauma-induced coagulopathy: the clot thickens or not?. J Trauma Acute Care Surg 2015; 79 (02) 301-309
• 4 Dobson GP, Letson HL. Adenosine, lidocaine, and Mg2+ (ALM): from cardiac surgery to combat casualty care--teaching old drugs new tricks. J Trauma Acute Care Surg 2016; 80 (01) 135-145
• 5 Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med 2014; 370 (09) 847-859
• 6 Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management in patients with severe burns. J Thromb Haemost 2016; 14 (05) 865-874
• 7 Leeper CM, Neal MD, Billiar TR, Sperry JL, Gaines BA. Overresuscitation with plasma is associated with sustained fibrinolysis shutdown and death in pediatric traumatic brain injury. J Trauma Acute Care Surg 2018; 85 (01) 12-17
• 8 Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54 (06) 1127-1130
• 9 Brohi K, Cohen MJ, Ganter MT. , et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64 (05) 1211-1217 , discussion 1217
• 10 Maegele M, Spinella PC, Schöchl H. The acute coagulopathy of trauma: mechanisms and tools for risk stratification. Shock 2012; 38 (05) 450-458
• 11 Cohen MJ, Kutcher M, Redick B. , et al; PROMMTT Study Group. Clinical and mechanistic drivers of acute traumatic coagulopathy. J Trauma Acute Care Surg 2013; 75 (01) (Suppl. 01) S40-S47
• 12 White NJ. Mechanisms of trauma-induced coagulopathy. Hematology (Am Soc Hematol Educ Program) 2013; 2013: 660-663
• 13 Moore EE, Moore HB, Chapman MP, Gonzalez E, Sauaia A. Goal-directed hemostatic resuscitation for trauma induced coagulopathy: maintaining homeostasis. J Trauma Acute Care Surg 2018; 84 (6S, Suppl 1): S35-S40
• 14 MacFarlane RG, Biggs R. Observations on fibrinolysis; spontaneous activity associated with surgical operations, trauma, etc. Lancet 1946; 2 (6433): 862-864
• 15 Tagnon HJ, Levenson SM, Davidson CS, Taylor FHI. The occurrence of fibrinolysis in shock, with observations on the prothrombin time and the plasma fibrinogen during hemorrhagic shock. Am J Med Sci 1946; 211 (01) 88-96
• 16 Stefanini M. Fibrinolysis and “fibrinolytic purpura.”. Blood 1952; 7 (10) 1044-1046
• 17 McNamara JJ, Burran EL, Stremple JF, Molot MD. Coagulopathy after major combat injury: occurrence, management, and pathophysiology. Ann Surg 1972; 176 (02) 243-246
• 18 Stefanini M. Diffuse intravascular coagulation: an analysis of a basic mechanism of disease. CRC Crit Rev Clin Lab Sci 1972; 3 (03) 349-378
• 19 Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg 2011; 254 (01) 10-19
• 20 Gando S, Wada H, Thachil J. ; Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis (ISTH). Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost 2013; 11 (05) 826-835
• 21 Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers 2016; 2: 16037
• 22 Hayakawa M. Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intensive Care 2017; 5: 14
• 23 Wohlauer MV, Moore EE, Thomas S. , et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg 2012; 214 (05) 739-746
• 24 Gando S, Mayumi T, Ukai T. Activated protein C plays no major roles in the inhibition of coagulation or increased fibrinolysis in acute coagulopathy of trauma-shock: a systematic review. Thromb J 2018; 16: 13
• 25 MacLeod JB, Winkler AM, McCoy CC, Hillyer CD, Shaz BH. Early trauma induced coagulopathy (ETIC): prevalence across the injury spectrum. Injury 2014; 45 (05) 910-915
• 26 Gonzalez E, Moore EE, Moore HB, Chapman MP, Silliman CC, Banerjee A. Trauma-induced coagulopathy: an institution's 35 year perspective on practice and research. Scand J Surg 2014; 103 (02) 89-103
• 27 Frith D, Goslings JC, Gaarder C. , et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8 (09) 1919-1925
• 28 Cap A, Hunt B. Acute traumatic coagulopathy. Curr Opin Crit Care 2014; 20 (06) 638-645
• 29 Maegele M. The coagulopathy of trauma. Eur J Trauma Emerg Surg 2014; 40 (02) 113-126
• 30 Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood 2018; 131 (08) 845-854
• 31 Thachil J. The elusive diagnosis of disseminated intravascular coagulation: does a diagnosis of DIC exist anymore?. Semin Thromb Hemost 2019; 45 (01) 100-107
• 32 Rizoli S, Nascimento Jr B, Key N. , et al. Disseminated intravascular coagulopathy in the first 24 hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma 2011; 71 (05) (Suppl. 01) S441-S447
• 33 Wiegele M, Kozek-Langenecker S, Schaden E. Point-of-care testing in burn patients. Semin Thromb Hemost 2017; 43 (04) 433-438
• 34 Huzar TF, Martinez E, Love J. , et al. Admission rapid thrombelastography (rTEG®) values predict resuscitation volumes and patient outcomes after thermal injury. J Burn Care Res 2018; 39 (03) 345-352
• 35 Welling H, Ostrowski SR, Stensballe J. , et al. Management of bleeding in major burn surgery. Burns 2019; 45 (04) 755-762
• 36 Wiegele M, Schaden E, Koch S, Bauer D, Krall C, Adelmann D. Thrombin generation in patients with severe thermal injury. Burns 2019; 45 (01) 54-62
• 37 Stettler GR, Moore EE, Moore HB. , et al. Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays. J Trauma Acute Care Surg 2019; 86 (04) 679-685
• 38 Kornblith LZ, Kutcher ME, Redick BJ, Calfee CS, Vilardi RF, Cohen MJ. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 2014; 76 (02) 255-256 , discussion 262–263
• 39 Gall LS, Vulliamy P, Gillespie S. , et al; Targeted Action for Curing Trauma-Induced Coagulopathy (TACTIC) partners. The S100A10 pathway mediates an occult hyperfibrinolytic subtype in trauma patients. Ann Surg 2019; 269 (06) 1184-1191
• 40 Sumislawski JJ, Christie SA, Kornblith LZ. , et al. Discrepancies between conventional and viscoelastic assays in identifying trauma-induced coagulopathy. Am J Surg 2019; 217 (06) 1037-1041
• 41 Litvinov RI, Weisel JW. Not fibrin(ogen), but fibrinogen or fibrin. Blood 2015; 126 (17) 1977-1978
• 42 Floccard B, Rugeri L, Faure A. , et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43 (01) 26-32
• 43 Simmons JW, Pittet JF, Pierce B. Trauma-induced coagulopathy. Curr Anesthesiol Rep 2014; 4 (03) 189-199
• 44 Letson HL, Dobson GP. Differential contributions of platelets and fibrinogen to early coagulopathy in a rat model of hemorrhagic shock. Thromb Res 2016; 141 (March): 58-65
• 45 Moore HB, Moore EE, Chapman MP. , et al. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients. J Thromb Haemost 2015; 13 (10) 1878-1887
• 46 St John AE, Newton JC, Martin EJ. , et al. Platelets retain inducible alpha granule secretion by P-selectin expression but exhibit mechanical dysfunction during trauma-induced coagulopathy. J Thromb Haemost 2019; 17 (05) 771-781
• 47 Letson HL, Dobson GP. Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis. J Trauma Acute Care Surg 2015; 78 (04) 773-783
• 48 Kutcher ME, Redick BJ, McCreery RC. , et al. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg 2012; 73 (01) 13-19
• 49 Solomon C, Traintinger S, Ziegler B. , et al. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost 2011; 106 (02) 322-330
• 50 Harr JN, Moore EE, Ghasabyan A. , et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013; 39 (01) 45-49
• 51 Cardenas JC, Rahbar E, Pommerening MJ. , et al. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma. J Trauma Acute Care Surg 2014; 77 (06) 839-845
• 52 Winearls J, Campbell D, Hurn C. , et al. Fibrinogen in traumatic haemorrhage: a narrative review. Injury 2017; 48 (02) 230-242
• 53 Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54 (05) 1389-1405 , quiz 1388
• 54 Marsden M, Benger J, Brohi K. , et al; CRYOSTAT-2 investigators. Coagulopathy, cryoprecipitate and CRYOSTAT-2: realising the potential of a nationwide trauma system for a national clinical trial. Br J Anaesth 2019; 122 (02) 164-169
• 55 Hofer V, Wrigge H, Wienke A, Hofmann G, Hilbert-Carius P. Platelet function disorder in trauma patients, an underestimated problem? Results of a single center study [in German]. Anaesthesist 2019; 68 (06) 368-376
• 56 Letson H, Dobson G. Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. PLoS One 2017; 12 (11) e0188144
• 57 Letson HL, Dobson GP. Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury. J Trauma Acute Care Surg 2018; 84 (06) 908-916
• 58 Coleman JR, Moore EE, Kelher MR. , et al. Female platelets have distinct functional activity compared with male platelets: implications in transfusion practice and treatment of trauma-induced coagulopathy. J Trauma Acute Care Surg 2019; 87 (05) 1052-1060
• 59 Mullin JL, Gorkun OV, Binnie CG, Lord ST. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release. J Biol Chem 2000; 275 (33) 25239-25246
• 60 Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3 (08) 1894-1904
• 61 Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem 2017; 82: 405-456
• 62 Innes D, Sevitt S. Coagulation and fibrinolysis in injured patients. J Clin Pathol 1964; 17: 1-13
• 63 Kutcher ME, Cripps MW, McCreery RC. , et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg 2012; 73 (01) 87-93
• 64 Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schöchl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med 2013; 21: 74
• 65 Rourke C, Curry N, Khan S. , et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10 (07) 1342-1351
• 66 Raza I, Davenport R, Rourke C. , et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11 (02) 307-314
• 67 Moore HB, Moore EE, Neal MD. , et al. Fibrinolysis shutdown in trauma: historical review and clinical implications. Anesth Analg 2019; 129 (03) 762-773
• 68 Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147 (02) 113-119
• 69 Roberts I, Shakur H, Coats T. , et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013; 17 (10) 1-79
• 70 Roberts I. Tranexamic acid in trauma: how should we use it?. J Thromb Haemost 2015; 13 (Suppl. 01) S195-S199
• 71 Dobson GP, Doma K, Letson HL. Clinical relevance of a p value: does tranexamic acid save lives after trauma or postpartum hemorrhage?. J Trauma Acute Care Surg 2018; 84 (03) 532-536
• 72 Moore HB, Moore EE, Gonzalez E. , et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 2014; 77 (06) 811-817 , discussion 817
• 73 Walsh M, Shreve J, Thomas S. , et al. Fibrinolysis in trauma: “myth,” “reality,” or “something in between.”. Semin Thromb Hemost 2017; 43 (02) 200-212
• 74 Myers SP, Kutcher ME, Rosengart MR. , et al. Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg 2019; 86 (01) 20-27
• 75 Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia 2015; 70 (Suppl. 01) 78-86 , e27–e28
• 76 Moore HB, Moore EE, Lawson PJ. , et al. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock. Surgery 2015; 158 (02) 386-392
• 77 Moore HB, Moore EE, Liras IN. , et al. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients. J Am Coll Surg 2016; 222 (04) 347-355
• 78 Cardenas JC, Wade CE, Cotton BA. , et al; PROPPR Study Group. TEG lysis shutdown represents coagulopathy in bleeding trauma patients: analysis of the PROPPR cohort. Shock 2019; 51 (03) 273-283
• 79 Gomez-Builes JC, Acuna SA, Nascimento B, Madotto F, Rizoli SB. Harmful or physiologic: diagnosing fibrinolysis shutdown in a trauma cohort with rotational thromboelastometry. Anesth Analg 2018; 127 (04) 840-849
• 80 Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta 2000; 1477 (1-2): 349-360
• 81 Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106 (08) 2605-2612
• 82 Chahal G, Thorpe M, Hellman L. The importance of exosite interactions for substrate cleavage by human thrombin. PLoS One 2015; 10 (06) e0129511
• 83 Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood 2018; 132 (02) 148-158
• 84 Lechtenberg BC, Freund SMV, Huntington JA. GpIbα interacts exclusively with exosite II of thrombin. J Mol Biol 2014; 426 (04) 881-893
• 85 Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol 2012; 34 (01) 107-125
• 86 Esmon CT. Protein C anticoagulant system--anti-inflammatory effects. Semin Immunopathol 2012; 34 (01) 127-132
• 87 McCarron JG, Lee MD, Wilson C. The endothelium solves problems that endothelial cells do not know exist. Trends Pharmacol Sci 2017; 38 (04) 322-338
• 88 Esmon CT. The protein C pathway. Chest 2003; 124 (3, Suppl): 26S-32S
• 89 Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas 2004; 47 (04) 305-314
• 90 Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?. Ann Med 2006; 38 (06) 378-388
• 91 Dassah M, Deora AB, He K, Hajjar KA. The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys 2009; 28 Spec No Focus: F20-F28
• 92 Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA, Waisman DM. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood 2011; 118 (18) 4789-4797
• 93 Hedhli N, Falcone DJ, Huang B. , et al. The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol 2012; 2012: 406273
• 94 Luo M, Hajjar KA. Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost 2013; 39 (04) 338-346
• 95 Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995; 9 (10) 946-955
• 96 Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM. Regulation of fibrinolysis by S100A10 in vivo. Blood 2011; 118 (11) 3172-3181
• 97 Qu D, Wang Y, Esmon NL, Esmon CT. Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. J Thromb Haemost 2007; 5 (02) 395-402
• 98 Brownstein C, Deora AB, Jacovina AT. , et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood 2004; 103 (01) 317-324
• 99 Cannon WB. Traumatic Shock. New York, NY: D. Appleton and Co.; 1923
• 100 Lombardi F, Stein PK. Origin of heart rate variability and turbulence: an appraisal of autonomic modulation of cardiovascular function. Front Physiol 2011; 2: 95
• 101 Huston JM, Tracey KJ. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011; 269 (01) 45-53
• 102 Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 2013; 50 (05) 477-487
• 103 Sykora M, Czosnyka M, Liu X. , et al. Autonomic impairment in severe traumatic brain injury: a multimodal neuromonitoring study. Crit Care Med 2016; 44 (06) 1173-1181
• 104 Johansson PI, Henriksen HH, Stensballe J. , et al. Traumatic endotheliopathy: a prospective observational study of 424 severely injured patients. Ann Surg 2017; 265 (03) 597-603
• 105 Dobson GP, Letson HL, Grant A. , et al. Defining the osteoarthritis patient: back to the future. Osteoarthritis Cartilage 2018; 26 (08) 1003-1007
• 106 Morris JL, Letson HL, Gillman R. , et al. The CNS theory of osteoarthritis: opportunities beyond the joint. Semin Arthritis Rheum 2019; 49 (03) 331-336
• 107 Cholley B, Le Gall A. Ventriculo-arterial coupling: the comeback?. J Thorac Dis 2016; 8 (09) 2287-2289
• 108 Suga H, Goto Y, Kawaguchi O. , et al. Ventricular perspective on efficiency. In: Burkhoff D, Schaefer J, Schaffner K, Yue DT. , eds. Myocardial Optimization and Efficiency, Evolutionary Aspects and Philosophy of Science Considerations. New York, NY: Springer-Verlag; 1993: 43-65
• 109 London GM. Role of arterial wall properties in the pathogenesis of systolic hypertension. Am J Hypertens 2005; 18 (1 Pt 2): 19S-22S
• 110 Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005; 46 (01) 185-193
• 111 Guarracino F, Baldassarri R, Pinsky MR. Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care 2013; 17 (02) 213-220
• 112 Dobson GP, Arsyad A, Letson HL. The adenosine hypothesis revisited: modulation of coupling between myocardial perfusion and arterial compliance. Front Physiol 2017; 8: 824
• 113 Onorati F, Santini F, Dandale R. , et al. “Polarizing” microplegia improves cardiac cycle efficiency after CABG for unstable angina. Int J Cardiol 2013; 167 (06) 2739-2746
• 114 Ky B, French B, May Khan A. , et al. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol 2013; 62 (13) 1165-1172
• 115 Axell RG, Messer SJ, White PA. , et al. Ventriculo-arterial coupling detects occult RV dysfunction in chronic thromboembolic pulmonary vascular disease. Physiol Rep 2017; 5 (07) e13227
• 116 Antonini-Canterin F, Poli S, Vriz O, Pavan D, Bello VD, Nicolosi GL. The ventricular-arterial coupling: from basic pathophysiology to clinical application in the echocardiography laboratory. J Cardiovasc Echogr 2013; 23 (04) 91-95
• 117 Granfeldt A, Letson HL, Hyldebrandt JA. , et al. Small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ has multiple benefits during hypotensive and blood resuscitation in the pig following severe blood loss: rat to pig translation. Crit Care Med 2014; 42 (05) e329-e344
• 118 Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125 (03) 926-938
• 119 Tillisch K. The effects of gut microbiota on CNS function in humans. Gut Microbes 2014; 5 (03) 404-410
• 120 Liang X, FitzGerald GA. Timing of microbes: the circadian rhythm of the gut microbiome. J Biol Rhythms 2017; 32 (06) 505-515
• 121 Dobson GP, Letson HL, Biros E, Morris J. Specific pathogen-free (SPF) animal status as a variable in biomedical research: have we come full circle?. EBioMedicine 2019; 41 (March): 42-43
• 122 Letson HL, Morris J, Biros E, Dobson GP. Conventional and specific-pathogen free rats respond differently to anesthesia and surgical trauma. Sci Rep 2019; 9 (01) 9399
• 123 Howard BM, Kornblith LZ, Christie SA. , et al. Characterizing the gut microbiome in trauma: significant changes in microbial diversity occur early after severe injury. Trauma Surg Acute Care Open 2017; 2 (01) e000108
• 124 Matteoli G, Boeckxstaens GE. The vagal innervation of the gut and immune homeostasis. Gut 2013; 62 (08) 1214-1222
• 125 Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 2009; 24 (05) 293-316
• 126 Dobson GP. Addressing the global burden of sepsis: importance of a systems-based approach. Crit Care Med 2014; 42 (12) e797-e798
• 127 Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb Haemost 2005; 3 (07) 1392-1406
• 128 Huang ML, Godula K. Nanoscale materials for probing the biological functions of the glycocalyx. Glycobiology 2016; 26 (08) 797-803
• 129 van Hinsbergh VW. Endothelium--role in regulation of coagulation and inflammation. Semin Immunopathol 2012; 34 (01) 93-106
• 130 Bennett HS. Morphological aspects of extracellular polysaccharides. J Histochem Cytochem 1963; 11: 14-23
• 131 Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc 1966; 25 (06) 1773-1783
• 132 Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454 (03) 345-359
• 133 Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004; 84 (03) 869-901
• 134 Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108 (03) 384-394
• 135 Aditianingsih D, George YWH. Guiding principles of fluid and volume therapy. Best Pract Res Clin Anaesthesiol 2014; 28 (03) 249-260
• 136 Chappell D, Jacob M. Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol 2014; 28 (03) 227-234
• 137 Tiruppathi C, Minshall RD, Paria BC, Vogel SM, Malik AB. Role of Ca2+ signaling in the regulation of endothelial permeability. Vascul Pharmacol 2002; 39 (4-5): 173-185
• 138 Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009; 22 (02) 155-162
• 139 Biddle C. Like a slippery fish, a little slime is a good thing: the glycocalyx revealed. AANA J 2013; 81 (06) 473-480
• 140 Naumann DN, Hazeldine J, Davies DJ. , et al. Endotheliopathy of trauma is an on-scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study. Shock 2018; 49 (04) 420-428
• 141 Zeng Y, Tarbell JM. The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS One 2014; 9 (01) e86249
• 142 Luft JH. The structure and properties of the cell surface coat. Int Rev Cytol 1976; 45: 291-382
• 143 Torres Filho IP, Torres LN, Salgado C, Dubick MA. Novel adjunct drugs reverse endothelial glycocalyx damage after hemorrhagic shock in rats. Shock 2017; 48 (05) 583-589
• 144 Letson HL, Pecheniuk NM, Mhango LP, Dobson GP. Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaCl adenocaine and Mg2+ in the rat model of severe hemorrhagic shock. Crit Care Med 2012; 40 (08) 2417-2422
• 145 Ostrowski SR, Gaïni S, Pedersen C, Johansson PI. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study. J Crit Care 2015; 30 (01) 90-96
• 146 Ostrowski SR, Henriksen HH, Stensballe J. , et al. Sympathoadrenal activation and endotheliopathy are drivers of hypocoagulability and hyperfibrinolysis in trauma: a prospective observational study of 404 severely injured patients. J Trauma Acute Care Surg 2017; 82 (02) 293-301
• 147 Thurairajah K, Briggs GD, Balogh ZJ. The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies. Eur J Trauma Emerg Surg 2018; 44 (03) 325-334
• 148 Aswani A, Manson J, Itagaki K. , et al. Scavenging circulating mitochondrial DNA as a potential therapeutic option for multiple organ dysfunction in trauma hemorrhage. Front Immunol 2018; 9: 891
• 149 Dobson GP. On being the right size: heart design, mitochondrial efficiency and lifespan potential. Clin Exp Pharmacol Physiol 2003; 30 (08) 590-597
• 150 Hauser CJ, Otterbein LE. Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis. Eur J Trauma Emerg Surg 2018; 44 (03) 317-324
• 151 Zhao Z, Wang M, Tian Y. , et al. Cardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in mice. Blood 2016; 127 (22) 2763-2772
• 152 Boudreau LH, Duchez AC, Cloutier N. , et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014; 124 (14) 2173-2183
• 153 Brohi K, Gruen RL, Holcomb JB. Why are bleeding trauma patients still dying?. Intensive Care Med 2019; 45 (05) 709-711
• 154 Shoemaker WC, Beez M. Pathophysiology, monitoring, and therapy of shock with organ failure. Appl Cardiopulm Pathophysiol 2010; 14: 5-15
• 155 Yurdagul Jr A, Finney AC, Woolard MD, Orr AW. The arterial microenvironment: the where and why of atherosclerosis. Biochem J 2016; 473 (10) 1281-1295
• 156 Letson HL, Dobson GP. 3% NaCl adenosine, lidocaine, Mg2+ (ALM) bolus and 4 hours “drip” infusion reduces noncompressible hemorrhage by 60% in a rat model. J Trauma Acute Care Surg 2017; 82 (06) 1063-1072
• 157 Letson HL, Morris JL, Biros E, Dobson GP. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: a model for studying differential gene expression and extending biological time. J Trauma Acute Care Surg 2019; 87 (03) 606-613
• 158 Downing NS, Shah ND, Aminawung JA. , et al. Postmarket safety events among novel therapeutics approved by the US Food and Drug Administration between 2001 and 2010. JAMA 2017; 317 (18) 1854-1863